FIELD: pharmacology.
SUBSTANCE: invention is a diuretic agent containing a 0.5% solution of fulvic acids in an amount of 40 ml and manganese oxide in an amount of 0.1 g.
EFFECT: invention allows to increase the therapeutic effect and to exclude occurrence of side effects.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIURETIC | 2016 |
|
RU2619348C1 |
DIURETIC | 2016 |
|
RU2619346C1 |
AGENTS WITH DIURETIC ACTIVITY | 2016 |
|
RU2619350C1 |
AGENT WITH DIURETIC ACTIVITY | 2016 |
|
RU2619349C1 |
DIURETIC | 2011 |
|
RU2456002C1 |
DRUG PREPARATION POSSESSING DIURETIC ACTIVITY | 2011 |
|
RU2485966C1 |
METHOD FOR SIMULATING POST-ISCHEMIC RENAL INSUFFICIENCY | 2012 |
|
RU2481646C1 |
USE OF PINOSTROBIN AS DIURETIC AND CREATINURETIC AGENT | 2023 |
|
RU2816948C1 |
PELOID HYMATOMELANIC ACID ANALYSIS METHOD | 2006 |
|
RU2338188C2 |
USE OF PINOCEMBRIN AS DIURETIC AND CREATININURETIC AGENT | 2023 |
|
RU2822937C1 |
Authors
Dates
2017-07-07—Published
2016-04-18—Filed